Gabon vs Zambia: Cause of death, by non-communicable diseases, ages 5-14, female
Gabon
15.8%
in 2021
Zambia
16.2%
in 2021
Gabon rank
175th
Zambia rank
174th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Gabon
- Zambia
How they compare
Zambia currently reports 16.2% against 15.8% in Gabon, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Gabon ahead.
Gabon ranks 175th and Zambia ranks 174th of 184 countries.
Across the 3 decades both report, Gabon averaged higher in 2 and Zambia in 1.
Head to head by decade
| Decade | Gabon | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.2% | 7.2% | 2.1% | Gabon |
| 2010s | 14.6% | 9.6% | 5.0% | Gabon |
| 2020s | 15.8% | 16.1% | 0.4% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Gabon or Zambia?
- Zambia, at 16.2% against 15.8% in Gabon as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Gabon and Zambia?
- 0.4%, with Zambia ahead.
- How many years of comparable data are there for Gabon and Zambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Gabon and Zambia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Gabon ranks 175th and Zambia ranks 174th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.